MHLW Calls for Revision of Package Insert for Xalkori

June 3, 2015
The Ministry of Health, Labor and Welfare (MHLW) issued a notification on June 2 calling for the revision of the package insert for the non-small cell lung cancer treatment crizotinib (product name: Xalkori; Pfizer Japan). The notification, issued to the...read more